or Try an Advanced Search...

    Technical Analysis for GNPX - Genprex, Inc.

    Grade Last Price % Change Price Change
    F 1.10 -3.51% -0.04
    GNPX closed down 3.51 percent on Friday, November 22, 2024, on 5 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical GNPX trend table...
    Date Alert Name Type % Chg
    Fell Below 50 DMA Bearish 0.00%
    1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    MACD Bearish Centerline Cross Bearish -3.51%
    50 DMA Support Bullish -3.51%
    Narrow Range Bar Range Contraction -3.51%
    Wide Bands Range Expansion -3.51%
    Oversold Stochastic Weakness -3.51%
    Older End-of-Day Signals for GNPX ...

       Recent Intraday Alerts

    Alert Time
    Up 5% about 17 hours ago
    Up 3% about 17 hours ago
    Down 1% about 17 hours ago
    Up 2% about 17 hours ago
    Up 1% about 17 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    GNPX Chart by TradingView
    Basic chart:

    Profile

    Genprex Inc is a clinical stage gene therapy company. It develops therapies that carry cancer-fighting genes. Its initial product candidate is Oncoprex.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Cancer Biology Gene Therapy Medical Genetics Applied Genetics Medicinal Chemistry

    Is GNPX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 3 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 31 Genprex to Participate in 2024 BIO Europe Conference
    Oct 28 Looking Into Genprex's Recent Short Interest
    Oct 28 Genprex Collaborators Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer, Mesothelioma and Glioblastoma
    Oct 24 Genprex Announces Sponsored Research Agreement with The University of Michigan Rogel Cancer Center and Lung Cancer Study Collaboration with ALK Positive
    Oct 23 Why Stride Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket
    Oct 16 Genprex advances to highest dose in Phase I Acclaim-3 trial of Reqorsa
    Oct 15 Genprex Receives Safety Review Committee Approval to Advance to Highest Dose Group in Phase 1 Portion of Acclaim-3 Clinical Trial of Reqorsa® Gene Therapy in Combination with Tecentriq® in Extensive Stage Small Cell Lung Cancer
    Sep 23 Genprex Featured in CEO/CFO Magazine Discussing Novel Gene Therapies for Cancer and Diabetes
    Sep 19 Genprex Announces Formation of Mesothelioma Clinical Advisory Board
    Sep 9 Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy at the 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
    See more GNPX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 14.4
    52 Week Low 0.2806
    Average Volume 11,482,743
    200-Day Moving Average 2.07
    50-Day Moving Average 1.11
    20-Day Moving Average 1.72
    10-Day Moving Average 1.43
    Average True Range 0.34
    RSI (14) 44.13
    ADX 33.37
    +DI 27.54
    -DI 22.36
    Chandelier Exit (Long, 3 ATRs) 1.98
    Chandelier Exit (Short, 3 ATRs) 2.09
    Upper Bollinger Bands 2.62
    Lower Bollinger Band 0.83
    Percent B (%b) 0.15
    BandWidth 103.92
    MACD Line -0.04
    MACD Signal Line 0.09
    MACD Histogram -0.1266
    Fundamentals Value
    Market Cap 1.63 Million
    Num Shares 1.49 Million
    EPS -24.40
    Price-to-Earnings (P/E) Ratio -0.05
    Price-to-Sales 0.00
    Price-to-Book 0.55
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.28
    Resistance 3 (R3) 1.29 1.25 1.25
    Resistance 2 (R2) 1.25 1.20 1.24 1.24
    Resistance 1 (R1) 1.17 1.17 1.15 1.16 1.23
    Pivot Point 1.13 1.13 1.12 1.12 1.13
    Support 1 (S1) 1.05 1.08 1.03 1.04 0.97
    Support 2 (S2) 1.01 1.05 1.00 0.96
    Support 3 (S3) 0.93 1.01 0.95
    Support 4 (S4) 0.92